Skip to main content
Journal cover image

Survival in Patients Diagnosed With Lung Cancer After Low-Dose CT Screening.

Journal articles  - Journal Article
Harowicz, MR; Chai, J; Thomas, S; Tong, BC; Christensen, JD; Tailor, TD
Published in: J Am Coll Radiol
August 2026

OBJECTIVE: To evaluate survival and mortality in individuals diagnosed with lung cancer after lung cancer screening (LCS), and the association of mortality with patient and cancer characteristics. METHODS: Retrospective study at an academic medical center including patients receiving LCS between January 1, 2015, and June 30, 2020, and diagnosed with lung cancer through June 30, 2021, were included. Patients with lung cancer were followed in the electronic health record through May 30, 2024, to determine vital status and patient and cancer characteristics. Survival probabilities were estimated using Kaplan-Meier methodology. Mortality rates were calculated as the number of deaths divided by total person-years. Univariable and multivariable Cox proportional hazards regression models were used to evaluate associations between mortality and patient and cancer characteristics. RESULTS: In all, 141 individuals with lung cancer were included. Mean age (SD) at diagnosis was 68.5 (6.3) years. Most individuals (111 of 141, 78.7%) had screen-detected lung cancer. Stage I cancer was most common (70 of 141, 49.6%). Estimated 5-year survival (95% confidence interval) was 53.4% (45.4-62.9%). Mortality at median follow-up times of 3.1 and 5.2 years was 337 deaths and 317 deaths per 100,000 person-years, respectively. At multivariable analysis, higher cancer stage and non-screen-detected lung cancer status were associated with higher mortality (P < .001 for any stage >1; hazard ratio of screen-detected versus non-screen-detected cancer [95% confidence interval]: 3.16 [1.77-5.66]). DISCUSSION: Though screen-detected cancers were associated with lower mortality, mortality in screened patients with lung cancer was higher than the National Lung Screening Trial, showing outcomes in our single-center clinical LCS may differ from prior LCS research trials.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Coll Radiol

DOI

EISSN

1558-349X

Publication Date

August 2026

Volume

23

Issue

8

Start / End Page

1491 / 1498

Location

United States

Related Subject Headings

  • Tomography, X-Ray Computed
  • Survival Rate
  • Retrospective Studies
  • Radiation Dosage
  • Nuclear Medicine & Medical Imaging
  • Neoplasm Staging
  • Middle Aged
  • Male
  • Lung Neoplasms
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Harowicz, M. R., Chai, J., Thomas, S., Tong, B. C., Christensen, J. D., & Tailor, T. D. (2026). Survival in Patients Diagnosed With Lung Cancer After Low-Dose CT Screening. J Am Coll Radiol, 23(8), 1491–1498. https://doi.org/10.1016/j.jacr.2026.05.006
Harowicz, Michael R., Jingchen Chai, Samantha Thomas, Betty C. Tong, Jared D. Christensen, and Tina D. Tailor. “Survival in Patients Diagnosed With Lung Cancer After Low-Dose CT Screening.J Am Coll Radiol 23, no. 8 (August 2026): 1491–98. https://doi.org/10.1016/j.jacr.2026.05.006.
Harowicz MR, Chai J, Thomas S, Tong BC, Christensen JD, Tailor TD. Survival in Patients Diagnosed With Lung Cancer After Low-Dose CT Screening. J Am Coll Radiol. 2026 Aug;23(8):1491–8.
Harowicz, Michael R., et al. “Survival in Patients Diagnosed With Lung Cancer After Low-Dose CT Screening.J Am Coll Radiol, vol. 23, no. 8, Aug. 2026, pp. 1491–98. Pubmed, doi:10.1016/j.jacr.2026.05.006.
Harowicz MR, Chai J, Thomas S, Tong BC, Christensen JD, Tailor TD. Survival in Patients Diagnosed With Lung Cancer After Low-Dose CT Screening. J Am Coll Radiol. 2026 Aug;23(8):1491–1498.
Journal cover image

Published In

J Am Coll Radiol

DOI

EISSN

1558-349X

Publication Date

August 2026

Volume

23

Issue

8

Start / End Page

1491 / 1498

Location

United States

Related Subject Headings

  • Tomography, X-Ray Computed
  • Survival Rate
  • Retrospective Studies
  • Radiation Dosage
  • Nuclear Medicine & Medical Imaging
  • Neoplasm Staging
  • Middle Aged
  • Male
  • Lung Neoplasms
  • Humans